Post on 27-Jun-2020
AUTHOR INDEX
November 1985
Aardema, M. J., 5321Abiin, R. J., 5984Absolom, D. R., 5625Akman, S. A., 5257Alama, A., 5926Alvarez, E., 5294Andersen, R. A., 5287Anderson, A. B., 5473Anderson, S., 5914Ansari, G. A. S., 5617Archetti, Y. L., 5299Ardecky, R. J., 5563Aresca, P., 5299Aronson, D., 5521Arundel, C. M., 5557Ashwood-Smith, M., 5394Au, W. W., 5321Aune, T., 5859Azzam, E. I., 5452
Bachur, N. R., 5352Balaban, G., 5670Bartkus, J. M., 5984Basilion, J. P., 5787Batist, G., 5900Bauer, H. C. F., 5598Baumgartner, K. J., 5252Beamer, W. G., 5575Beatty, B. G., 5694, 5700Beatty, J. D., 5694, 5700Beer, D. S., 5751Belle, S. H., 5883Bend, J. R., 5859Bennicelli, J. L., 5670Bern, H. A., 5688Berns, M. W., 5781Bernstein, P., 5603Beyer, G. S., 5921Bigner, D. D., 5240Bigner, S. H., 5240Block, J. B., 5257Blumberg, P. M., 5540, 5714Böhmer,R. M., 5328Bondi, E., 5670Boothman, D. A., 5270Borden, E., 5914Borsa, J., 5452Boukamp, P., 5582Boyd, J. A., 5851Brattain, D. E., 5281Brattain, M. G., 5281Brissenden, J. E., 5593Brosjö,O., 5598Broström, L-À.,5598Bruno, E., 5921Bullard, D. E., 5240Burbeck, S., 5643Burton, M. A., 5390Busch, H., 5637Busch, R. K., 5637Bussolati, G., 5799Bystryn, J-C., 5603
Canavese, G., 5926Cames, B. A., 5379Carr, J. M., 5944Carson, R. E., 5547Cass, C. E., 5480Cerutti, P., 5890Cha, S., 5405
Chakrabarty, S., 5281Chambers, T. J., 5663Charnley, G., 5608Chatten, J., 5976Chen, C-J., 5895Chen, Y-H., 5473Cheung, N-K, V., 5969
Chheda, G. B., 5958Chida, K., 5426Chlebowski, R., 5257Chow, H., 5431Chu, T. M., 5984Chuang, Y-C., 5895
Clark, B. R., 5694Clark, W. H., 5670Clarke, C. L, 5417Cleaver, J. E., 5394, 5399Coccia, P. F., 5969Coffer, A. I., 5728Coffman, D. S., 5751Coleman, D. T., 5421Collier, G. R., 5734Combs, S. G., 5813Comoglio, P. M., 5799Conte, P. F., 5926Corsaro, E., 5926Costa, M., 5787Creaven, P. J., 5936Croft, J. E., 5859Crouch, L. S., 5617Cummings, S. W., 5617Cunningham, R., 5769
Darnowski, J. W., 5364David, S. L., 5625Davis, T., 5914de Bruijn, E. A., 5931DeLarco, B. M., 5563Del Vecchio, L., 5299DeMets, D., 5914Derynck, R., 5593Dexter, D. L., 5563Dicke, K. A., 5431Dietrich, M., 5257Dillman, R. O., 5632Dixon, D. O., 5952Djeu, J., 5643Dodion, P., 5352Drewinko, B., 5447, 5926Drogemuller, C. R., 5436Ducore, J. M., 5526Dunn, J. A., 5540Dusak, B. A., 5563Dutta, S. P., 5958Dvorak, A. M., 5944Dvorak, H. F., 5521,5944Dybing, E., 5859
Egorin, M. J., 5352Einspenner, M., 5452Elder, D. E., 5670Eling, T. E., 5851el Kouni, M. H., 5405Engisch, K. L., 5352Erìichman,C., 5939Esch, T., 5757
Fausto, N., 5762Fennell, T. R., 5310Ferguson, P. J., 5480
Ferrans, V. J., 5900Ferrane, S., 5877Flick, D. A., 5225Forbes, M., 5563Francke, U., 5593Fraschini, G., 5926Freeman, J. W., 5637Friedman, E., 5648Frost, P., 5294Fujiwara, K., 5442Fukushima, M., 5426Fusenig, N. E., 5582
Gallagher, B. M., 5824Garns, J., 5625Garland, W. A., 5457Gerson, S. L., 5969Gifford, G. E., 5225Gilbert, J., 5728Glicksman, A. S., 5557Goldstein, D., 5643Gonzalez-Rothi, R. J., 5225Gorelik, E., 5341Gould, V. E., 5808, 5813Gray, B. N., 5390Gray, J. W., 5795Ordina, D. J., 5379Green, M. V., 5547Greer, S. B., 5270Grossberg, S. E., 5369Gruenert, D. C., 5394, 5399Guengerich, F. P., 5617Guerry, D., 5670Gupta, R. C., 5656
Haberern, C. L., 5246Hagan, P. L., 5632Halpern, S. E., 5632Hamburger, A. W., 5369Hammond, D., 5904Hand, R. E., Jr., 5321Handschumacher, R. E., 5364Harris, A. L., 5304Harris, J. O., 5225Hartmann, K., 5890Hasegawa, M., 5230Hashiba, H., 5426Hawkins, M., 5914Hayatsu, H., 5867Heflich, R. H., 5461Heggie, J. C., 5390Herberman, R. B., 5341Herbert, M. A., 5625Heriyn, D., 5670, 5910Herlyn, M., 5670, 5964Herscovics, A., 5505Hesson, D. P., 5563Hickson, l. D., 5304Hildebrand-Zanki, S. U., 5436Hill, C. K., 5379Hirnes, T. R., 5964Hiramoto, K., 5867Ho, C-K., 5348Hoekstra, W. G., 5489, 5496Hoffman, R., 5921Hollenberg, P. F., 5219Hoppe, P. C., 5575Horan Hand, P., 5648Hori, M., 5230Horning, S., 5914
Horton, M. A., 5663Hosted, T. J., Jr., 5421House, S., 5835Hudson, J. L., 5757Huynh, L., 5431
Iguchi, T., 5688lizuka, S., 5835Imberti, L., 5877lozzo, R. V., 5677
Jackson, R. C., 5532Jakowatz, J. G., 5694, 5700Jeng, A. Y., 5540, 5714Johnson, D. E., 5632
Kaplan, N. O., 5263Katki, A. G., 5900Kato, K., 5722Keefer, L. K., 5457Kehrer, J. P., 5707Kemp, T. R., 5287Kennedy, M. C., 5436Kerbel, R. S., 5294Kem, D. H., 5436Kikuchi, Y., 5722Killian, C. S., 5984King, R. J. B., 5728Kinoshita, K., 5835Kitagawa, T., 5442Kitamura, Y., 5746Kizawa, l., 5722Klein-Szanto, A. J. P., 5707Kodell, R. L., 5461Konrad, M„5914Koprowska, l., 5964Koprowski, H., 5670, 5910Kovacs, G., 5335Krivit, W„5904Kubota, M., 5734Kufe, D. W., 5830Kulkarni, S. S., 5431Kupchik, H. Z., 5246Kurokawa, M., 5741Kuroki, T., 5426
Laishes, B. A., 5489, 5496Lampkin, B. C., 5904Lampson, L. A., 5976Latter, G., 5643LaVoie, E. J., 5421Leary, S. L., 5235Leavitt, J., 5643LeBoeuf, R. A., 5489, 5496Lee, H-J., 5512Lee, l., 5808, 5813Lee, M. Y., 5840Leith, J. T., 5557Leonard, J. E., 5263, 5632Leopold, W. R., 5532Leung, S. C., 5358Leventon, G. S., 5431Levine, A. S., 5904Levy, H., 5904Lewis, D., 5663Lewis, K., 5728Lichti, U, 5714Liliemark, J. O., 5952Limberg, P., 5257Lin, T-M., 5895
CANCER RESEARCH VOL. 45 NOVEMBER 1985
5992
AUTHOR INDEX
Liteplo, R. G., 5294Uu, L. F., 5872Uu, P., 5603LJvesey, S. A., 5734Long, B. H., 5281Longnecker, D. S., 5252Lundy, J., 5769
Ma, Y., 5808, 5813.MacLeod, M. C., 5741Madajewicz, S., 5936Mäher,M., 5900Makita, A., 5835Malkinson, A. M., 5751Mangino, M. M., 5219Mann, K. G., 5521Marshall, R. S., 5939Martin, D. S., 5374Martin, T. J., 5734Mathé,G., 5335Matsumoto, K., 5746McCaustland, D. J., 5421McCloskey, J. A., 5958McCoy, J. P., Jr., 5757McNulty, K., 5663Mekras, J. A., 5270Merigan, T., 5914Merz, G. E., 5757Mico, B. A., 5457Miller, E. C., 5310Miller, J. A., 5310Millis, R., 5728Mills, K. T., 5688Mitchell, R. H., 5394Mittelman, A., 5958Moley, J. F., 5547Momose, E., 5722Montgomery, J. A., 5958Moore, D. J., 5466Morra, I., 5799Morris, S. M., 5461Morrison, S. D., 5547Morstyn, G., 5328Moskwa, P. S., 5447Mukai, K., 5722Muller-Glauser, W., 5677Muraro, R., 5769Murphy, G. P., 5984Murphy, J. T., 5526Myers, C. E., 5900
Naguib, F. N. M., 5405Nakamura, H., 5442Narayanan, V. L., 5563Nash, R., 5728Negishi, K., 5867Nelson, J. M., 5532Nelson, J. S., 5781Ng, K. W., 5734Nguyen, B. T., 5512Nicolin, A., 5926Nilsonne, U., 5598Nilsson, 0. S., 5598
Nishizawa, Y., 5746Nissenson, R. A., 5358Noguchi, P., 5769Noguchi, S., 5746Norton, J. A., 5547, 5900Nowak, D., 5890Nowell, P., 5670
O'Dea, R. F., 5553
Oka, N., 5867Oldfield, N. F., 5457Ono, M., 5835Oomori, K., 5722Ostrander, P. L., 5688Overton, R., 5341
Panzica, M., 5762Patierno, S. R., 5787Patrzyc, H. B., 5958Paull, K. D., 5563Pawlak, K., 5512Paxton, R. J., 5694, 5700Pelley, R., 5969Pendyala, L., 5936Pappoloni, S., 5341Peraino, C., 5379Perruzzi, C. A., 5818Petropoulos, C. J., 5762Philben, V. J., 5700Philpot, R. M., 5851,5859Pinedo, H. M., 5931Pinkel, D., 5795Pittelkow, M. R., 5466Plowman, J., 5532, 5563Plunkett, W., 5952Porudominsky, D., 5700Powis, G., 5466Prat, M., 5799Preston, R. J., 5321Pringle, J. A. S., 5663Prough, R. A., 5617
Quander, R. V., 5235
Raaphorst, G. P., 5452Radosevich, J. A., 5808, 5813Raju, S., 5728Ramnaraine, M. L., 5553Rao, G. V., 5563Rauth, A. M., 5939Reeuwijk, H. J. E. M., 5931Reinholt, F. P., 5598Rice, J. E., 5421Richardson, R. L., 5466Ritzi, E. M., 5374Robins, R. K., 5512Robson, C. N., 5304Roebuck, B. D., 5252Roop, D. R., 5845Rosen, S. T., 5808, 5813Rosenstein, B. S., 5526Rosno, S., 5914Ross, B. E., 5637
Rosse, C., 5840Rosso, R., 5926Rowe, T. C., 5872Royston, l., 5263Rüdiger,H. W., 5890Rupniak, H. T. R., 5582
Saarinen, U. M., 5969Sadée,W., 5512Sadler, A. J., 5751Salwen, H. R., 5808Sands, H., 5824Sargent, M. D., 5452Salariano, W. A., 5883Sato, B., 5746Satyaswaroop, P. G., 5417Scarpelli, D. G., 5219Schade, W., 5757Schiesel, J., 5914Schlom, J., 5648, 5769Sears, H. F., 5910Sedmak, J. J., 5369Seki, K., 5722Sekiya, C., 5835Seif, G. W., 5390Senger, D. R., 5818Sethi, S. K., 5958Sethi, V. S., 5382, 5386Shafman, T. D., 5830Shah, S. A., 5824Shawler, D. L., 5632Sherman, M. L., 5830Shima, K., 5722Shively, J. E., 5694, 5700Siebenlist, R. E., 5369Sielaff, K., 5914Smith, C. R., 5625Smith, D. C., 5840Sondak, V. K., 5436Spiegelman, S., 5374Spriggs, D. R., 5830Squire, R. A., 5235Stahl, K-W., 5335Steiner, A. L., 5734Steplewski, Z., 5910Stiles, C. D., 5215Stolti, R. L., 5374Strandberg, J. D., 5235Strander, H., 5598Strewler, G. J., 5358Strickland, J. E., 5714Suda, T., 5426Sugiyama, M., 5787Swagzdis, J. E., 5457Swanson, G. M., 5883
Tanigawa, N., 5436Taniguchi, N., 5835Tannenbaum, S. R., 5608Taylor, R. W., 5728Testorelli, C., 5299Thimmaiah, K. N., 5382, 5386Thomas, E., 5840
Thompson, L. H., 5795Thor, A., 5648, 5769Thron, C. D., 5252Thurin, J., 5670Tippett, D. L., 5563Tjaden, U. R., 5931Toftgard, R., 5845Tongson, A., 5877Townsend, P. S., 5390Tracy, P. B., 5521Tribukait, B., 5598Tuchman, M., 5553Twardzik, D. R., 5413
Uchida, N., 5746Uehara, Y., 5230Umezawa, H., 5230
Vadasz, J. A., 5452Vadi, H., 5447Valentine, F., 5603VanDeWater, L., 5521Vanderìaan,M., 5795Vanderslice, R. R., 5851, 5859van Oosterom, A. T., 5931Varani, J., 5757Vlahos, W. G., 5694, 5700
Wagman, L., 5900Wakata, A., 5867Wang, M. C., 5984Wang, Q-c., 5263Wataya, Y., 5867Whelan, J. P., 5976White, C. P., 5369Whitten, W. K., 5575Wiley, J. C., Jr., 5421Williams, K. G., 5473Williams, L. E., 5694, 5700Williams, R. D., 5358Willson, J. K. V., 5281Wiseman, R. W., 5310Wright, W. H., 5781Wu, H-Y., 5895
Wunderlich, D., 5769
Yamaguchi, K., 5746Yang, C. S., 5569Yang, L., 5872Yarbrough, B. A., 5235Yaswen, P., 5762Yokosawa, N., 5835Yoo, J-S. H., 5569Yoshioka, A., 5867Youakim, A., 5505Yuspa, S. H., 5540, 5845
Zander, A. R., 5431Zhe, Z. N., 5835Ziai, M. R., 5877Zipfel, S. A., 5964
CANCER RESEARCH VOL. 45 NOVEMBER 1985
5993
U.S. Postal Service
STATEMENT OF OWNERSHIP. MANAGEMENT ANO CIRCULATIONRequired by 39 U.S.C. 3685)
1A. TITLE OF PUBLICATION
Cancer Research3. FREQUENCY OF ISSUE
Monthly
IB. PUBLICATION NO.
n l nln l gig n 173A. NO.OF ISSUESPUBLISHED
ANNUALLY
12
2. DATE OF FILING
October 1, 19853B. ANNUAL SUBSCRIPTION
PRICE
$175.004. COMPLETE MAILING ADDRESS OF KNOWN OFFICE OF PUBLICATION (Street, City, County, State and ZlPt4 Code) (Not printers)
428 E. Preston Street, Baltimore MH ?i?n?5. COMPLETE MAILING ADDRESS OF THE HEADQUARTERS OF GENERAL BUSINESS OFFICES OF THE PUBLISHER ¡Notprinter)
428 E. Preston Street. -,k: ore. Md ?1?np6. FULL NAMES AND COMPLETE MAILING ADDRESS OF PUBLISHER, EDITOR. AND MANAGING EDITOR /l'ha item MUST NOT be blank)
PUBLISHER (Name and Complete MailingAddress)Cancer Research, Inc.,428 East Preston Street. Baltimore. Md 21202
EDITOR (Namr and Complete MailingAddress)
Dr. Peter N. Magee, Fels Research Institute, Temple Univ. School of MedicinePhiladelphia.PA 19140
MANAGING EDITOR (Name and Complete MattingAddress)Ms. Margaret Poti, Pels Research Institute,Temple Univ. School of Medicine,Philadelphia,PA 19140
7. OWNER(¡fawnedby a corporation, its name and address must be stated and also immediately thereunder the names and addresses of stockholdersowning or holding I percent or more of total amount of stock. If not owned by a corporation, the names and addresses of the Individual owners mustbe given, if owned by a partnership or other unincorporated firm. Its name and address, as well as that of each individual must be given. If the publication is published by a nonprofit organization, its name and address must be stated.) (Item must be completed.)
FULL NAME
Cancer Research, Inc.COMPLETE MAILING ADDRESS
Temple University School ofPhiladelphia, PA 10140
8 KNOWN BONDHOLDERS, MORTGAGEES. AND OTHER SECURITY HOLDERS OWNING OR HOLDING 1 PERCENT OR MORE OF TOTALAMOUNT OF BONDS. MORTGAGES OR OTHER SECURITIES (If there are none, so state/
FULL NAME
NONE
COMPLETEMAILING ADDRESS
NONE
9. FOR COMPLETION BY NONPROFIT ORGANIZATIONS AUTHORIZED TO MAIL AT SPECIAL RATES (Section 423.I2DMM only)The purpose, function, and nonprofit status of this organization and tha exempt status for Federal income tax purposes ICheck one)
(1)HAS NOT CHANGED DURINGPRECEDING 12 MONTHS D
(2)HAS CHANGED DURINGPRECEDING 12 MONTHS
(If changed, publisher must submit explanation ofchange with this statement.)
10. EXTENT AND NATURE OF CIRCULATION(See instructions on reverse side)
A. TOTAL NO. COPIES (Net Press Run)
B. PAID AND/OR REQUESTED CIRCULATION* See below1. Sales through dealers and carriers, street vendors and counter sates
2. Mail Subscription(Paid and/or requested)
C. TOTAL PAID AND/OR REQUESTED CIRCULATION(Sum of 10BI and 10B2)
D. FREE DISTRIBUTION BY MAIL, CARRIER OR OTHER MEANSSAMPLES. COMPLIMENTARY, AND OTHER FREE COPIES
E. TOTAL DISTRIBUTION (SumofCandD)
F. COPIES NOT DISTRIBUTED1. Office use, left over, unaccounted, spoiled after printing
2. Return from News Agents
G. TOTAL (Sum of E. FI and 2-shoutd equal net press run shown in A)
11.I certify that the statements made byme above are correct and complete
AVERAGE NO. COPIES EACHISSUE DURING PRECEDING
12MONTHS
7300
192
59^0
6132
85
6217
1083
NONE
7300
ACTUAL NO. COPIES OF SINGLEISSUE PUBLISHED NEAREST TO
FILING DATE
6855
199
5913
6112
83
6195
660
NONE
6855SIGNATURE AND TITLE OF EDITOR, PUBLISHER, BUSINESS MANAGER. OR OWNER
PS Form 3526, July 1984
*"-»*—*-n ou/reverseI*(See instructionoufreversej*?aid subscribers mailed via Canada Post
CANCER RESEARCH VOL. 45 NOVEMBER 1985
5994
Q Tap«l ABCD Tap«2ABD Tap«3
P Tip«4ABD Tap«S
Notional Study Group UpdateWTERFEHONS/IMMUNOLOGYCUN1CALPHARMACOLOGYIGENITOURINARYCANCERI - Pradal«and Bladder
Drug Handling Safety
AMERICANSOCIETY OF
CLINICALONCOLOGY
AI:DIOt*SELECTED
VIUEO TAPES
ASCO-ONS lODfr WORKSHOPIssue»—Post-Present-Future
G Tape 6 ASCO-SSO JOINTWORKSHOP - Surgical Cure olMetastatic Disease
[_J Tap«7 Allog«n«lcBone Morrow Transplantation VersusChemotherapy for ANIL In Flnt Remission
D Tap«e Cancer In the ElderlyQl Tape 9 Innovation«In Clinical Trial MethodologyQ Tape 10 Cancer MétastasesQ Tape 11 FORUM - Legal Issues In Oncology •Computer»and
Information Retrieval In the Care oi Cancer PatientsQ Tape 12ABC CLINICALPHARMACOLOGYnQ Tap«13ABC PEDIATRICLEUKEMIALYMPHOMAD Tap* UAB GENITOURINARYCANCER0 - Test!»Q Tape 15ABC INTERFERONS,BIOLOGICALRESPONSEMODIFIERS.
AND AIDSD Tape 16ABCD BREAST CANCERD Tape 17AB PRESIDENTIALADDRESS Sydney E. Salmon
SIXTEENTHANNUAL DAVIDA. KARNOFSKY MEMORIALLECTURE-"Th«Oncologie End Gom«"Bruc«A. Chabner
REMARKSFROM THE DIRECTOR OF THE NATIONALCANCER INSTITUTE Vmc.nl T. D«Vita,Ir.
O Tap«18AB PLENARYSESSIONDOCTORS' RECEPTION OF THESE PLENARY PAPERSWAS ONE OF THE HIGHLIGHTS OF THE CONVENTION.THE VIDEO TAPES WILL DISSEMINATE MORE INFORMATION & WILL BE MORE PRODUCTIVE AS A SALES& TRAINING TOOL FOR YOUR PROFESSIONAL STAFF.
INTRODUCTORY PR1CE....$7S.OODisseminated Germ Cell Tumors: A Comparison ol
Cisplatin Plus Bleomyan Plus Either Vintaastine (PVB) or VP re (B£P¡.Non Small Cell Cancer: A Randomised Comparison ol
Chemotherapy with No ChemotherapyLate Intensilication Therapy in the Treatment ot Acute
Myetoid Leukemia /AMLiAdiuvant Therapy lor Osteosarcoma: A Random/ted
Prospective Trial.The Role ot Ad/avara Chemotherapy m the Treatment
ol Osteosarcoma (OS) ol the Extremity: Preliminary Results olthe Multi-institutional Osteosarcoma Study (M/OS)
The Eltectiveness ot 13-c«Retinole Acid Õ13-CRA)inthe Treatment ol Premaligrunt Lesions in Oral Cavity.
CMF Adiuvanl Programm Operable Breast Cancer withPositive Axillary Nodes: Ten-year Experience.
D Tape 19AB GYNECOLOGICAL TUMORS
D Tap«20ABC PSYCHOSOOAL ASPECTS OF CANCER/SUPPORTIVECAREO Tap«21ABC HEAD AND NEd CANCERD Tap«22AB LONGCANCERI - Non-Small Cell Lung Cancer
ASSOCIATION D TapeZSABCADULTHODGKWSDISEASEANDMALIGNANT;FOR CANCER? Q Tap.2<AB ADULTLEUKEMIAANDOTHERHEMATOLOGICAL
NEOPLASMSD Tape 2SABC PEDIATRICSOLID TUMORSD Tape 26ABC BRAINTUMORS/SARCOMAG Tape 27ABC BIOMARKERS.DIAGNOSIS.ANDEPIDEMIOLOGYD Tap«28ABC GASTROINTESTINALCANCERD Tap«29ABC LUNGCANCERU - Small Cell Lung Cancer
ALL "AB" TAPES DENOTE 2 TAPES IN SET ($23.00 each)ALL "ABC1 TAPES DENOTE 3 TAPES IN SET($34.50 each)
ALL "ABCD" TAPES DENOTE 4 TAPES IN SET|$46.00 each)
76THÃ:onnual ÃÕ«nestingÃ
VI
n DEO
RESEARCH.;::-:;ì;:.:.::,"MAY'.;:.',.,:.22-25 M '.':'.
mm «OSAS;*
Q Tap«30AB
Q Tap. 31
D Tap«32
D Tape 33AE
Q Tap«34ABQ Tap«3SABD Tap. 36AB
D Tape 37AB
Q Tape 38AB
O Tape 39
O Tape 40AED Tap«41ABC
O Tap«42AB
O Tape 43ABC
G Tap«<4ABCD Tape 45ABC
D Tape 46AB
D Tap«47
D Tap«46
Q Tap«49ABQ Tape 50
D Tap«SlAfiD Tape 52ABC
Q Tap«S3ABCD Tspe 54ABC
D Tap«55ABCD Tape 56ABCD Tape 57ABCD Tape 58ABD Tape 59ABD Tape 60AE
D Tap. 61ABD Tap. 62AB
D Tspe 63AB
D Tap. 64AB
Discount»1-5Up«6-11tape»12-24tape»25-48 tape»49 or moratap««
Sll.50a.cli(11.00 eachJ10.!,ll«chSill.lid «act
. »9.50each
Complete ASCO SetList PriceYOU SAVESet Price. .
Tapes 1-29
. . .$736.00. . . $161.00. . $575.00
D Tape 65AB
Complete Joint Conference
List Price $1610.00
SYMPOSIUMI - Oncogen««.Growth Regulation, andCancer - Joint AACR 'ASCO SymposiumCAIN MEMORIALAWARDLECTURE-"AntltumorAnthracycltn** Federica Arcamon«SCIENTIFIC ANDPUBLICAFFAIRSSYMPOSIUM-Nontradltlonol Source«oi Support for Cancer Reeearch-Pro«and Con»PREOJNICALPHARMACOLOGYm - ».varo DrugEvaluationVIROLOGYI - Viral CardnogeneaU IEPIDEMIOLOGYI - Cancer EpidemiologyCLINICAL INVESTIGATIONS DI - Uukemla/Lymphoma DBIOCHEMISTRYI - Biochemistry ol Human Turnara-MlnisympceiumCLINICALINVESTIGATIONSIV - Clinical Trial. - SolidTurnan ITHE RICHARD AND FONDAROSENTHAL FOUNDATIONAWARDLECTURE-'Monoclonal Antibodiee to Tumor
Antlgena and Oncogene Product»in the Management ofHuman Carcinoma»JeffreySchlomCLINICALINVESTIGATIONSV - Pediatrie NeoplasmiEXPERIMENTALTHERAPEUTICSID - AlkylotlngAgent»!PRJECUN1CALPHARMACOLOGYV - Cellular andSywtemlc Drug DistributionBIOLOGYIV - »ration and Metanoli».RHOADS MEMORIALAWARDLECTURE-"Tumor
Inrosion and Métastases:Role of the ExtracellularMatrix Lance A. LottoEXPERIMENTALTHERAPEUTICSIV - AntUolotee DCARONOGENESIS IV - Role of Oxygen Radical«InTumor Promotion - MlntaympoilumSYMPOSIUM D - Cellular Merhanl«nnof DrugRedstone»PRESIDENTIALADDRESS -" Macrophage«andMetastasis: A Biological Approach to Cancer Therapy"
baùli J. FidisiANNUAL BUSINESS MEETING of Ih«AmericanAssociation for f°jtn*~rResearchSYMPOSIUMID - Mechanism»of Tumor ProgressionG.HJl. CLOWES MEMORIALAWARDLECTURE-"HowIs Blood Vessel Growth Regulated In Normal andNeoplastlc Tls»ue?'ïud»hFolkman
IMMUNOLOGYVI - Antigens on Tumor CellsEXPERIMENTALTHERAPEUTICSVu - Anthracyclineeand other DNA Binden or Intercalate«»ICARCINOGENESISXI - DNA Repair and Mutagenesi»nENDOCRINOLOGYm - Endocrine Regulation of BreastCfmrer - MinisymposiumCARCINOGENESISXU - Early Event»In Cardnogeneai.BIOLOGYVII - Oncogene ExpressionPRECUNICAL PHARMACOLOGY K - Drug Resistane« IIMMUNOLOGYTO - LymphoUnes •MlnlsymposiumBIOCHEMISTRYV - Nucleic Add»EXPERIMENTALTHERAPEUTICSX - PyrlmldlneAnumetobolltesCARCINOGENESISXVI - Transformation DIMMUNOLOGYDC- Monoclonal Annbodlee forDiagnosi»and TherapyBIOLOGYDC- Colonie Cell Culture/Growth andSuppressor Factor»CARCINOGENESISXVH - Non-Cytochrome P-4SO-medloted Carcinogen Metabolism and Activation •MlnlsymposiumSYMPOSIUMIV - Recent Progress In Cancer R.March
YOU SAVESet Price. .
. $ 420.00. $1190.00
Toexpediteorders,pleaseincludeprogram#69o-85R Shipto (PLEASEPRINT):
CHECK BOXESFOR TAPESELECTION
Send To:AUDIO-STATS
EDUCATIONAL
SERVICES924 N. Market St.,
2nd Floor,Ingle wood, CA
90302
Complete AACR Set Topes 30-65
LastPrice $874.00YOU SAVE $189.00Set Price $685.00
D Pleasesendmethecompletesetoftapesfor
i•ALLSALESAREFINAL•Returneddefectivetapeswili be replacedfreeof charge•Californiaresidentsadd 6Vz%salestax •Shippingchargesare $1.00 tor first tapeand$ .50 for eachadditionaltape up to $ 10.00maximum«FOREIGNORDERSADD20% FORHANDLINGANDSHIPPINGSURFACESHIPPINGADD10% •WeacceptVisa, Mastercard,AmericanExpressand personaland companychecks •MINIMUMCREDITCARDORDERIS$20.00•MAILORDERS:ALLOW2-4 WEEKSFORDELIVERY«MAKECHECKSPAYABLETO:
AUDIOSTATSEDUCATIONALSERVICESO Checkenclosed
Name.
Address
City/State/Zip.
TotalPrice$ ,
SalesTax$ _
.Shipping $
.Amount Enclosed$
D Pleasechargemy:D Visa
AccountNumberSignature
D Mastercard G AmericanExpress
__ ExpirationDate_
TO ORDER VIDEO ORMORE THAN 6 AUDIO TAPESWITH YOUR CREDIT CARDCall Toll Free..800-367-8821In Callfornla..800-848-8821
ALL OTHER ORDERSCall....213-673-8821
WHEN ORDERINGVIDEO TAPES
SPECIFY FORMAT
QVHSQBETA
UAL DELIVERY FORCANCER RESEARCH.
ALZET*OSMOTICPUMPSFORCONVENIENT,RESULTS-ORIENTEDDRUGDELIVERY
ALZET: FOR CONTINUOUS DOSAGE
Alzet Osmotic Pumps offer thechoice of 1-4weeks of delivery, night
and day, for continuous presence ofeven the shortest half-life agent.
ALZET: FOR RESULTS
11t11••
II11111111
111111
11111II•
1II•
I•I1I1I111
11
II1II1II1
1 1TIME
ALZET: FOR CONVENIENCE
Subcutaneous implantation can becompleted in less than one minute. Itis easily mastered. In fact, ALZACorporation loans, free-of-charge, a
videocassette showing subcutaneous
and other implantation procedures.
Multiday infusions ensure that youmeasure the fully developed actionsof your test agent in the steady-state.
Single-dose studies are useful, but the
actions of many agents are far from
fully developed by a single dose. Theversatility of the Alzet Osmotic Pumpshas been demonstrated in over a thou
sand publications.
ALZET: FOR CANCER RESEARCHAPPLICATIONS
Alzet Osmotic Pumps have beensuccèsfully used for the administrationof many agents used in cancer researchincluding bleomycin, cisplatin, citro-
vorum factor, methotrexate, acivicin,5-fluorouracil, and peplomycin.
To place an order, call toll-free800-227-9953. In California, Alaska,
Hawaii and Canada, call collect(415) 494-5067. For more information,
mail the coupon below.
rOSMOnC PUMPS
Please send me informationon the Alzet Osmotic Pumps.
Name-
Affiliation _
Address
City „State. .Zip.
Mailto: ALZA Corporation ,,-Department Y,P.O. Box I0950950 Page Mill RoadPalo Alto, CA 94303-9990
C-CR